Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Unlike melatonin, DSIP remains experimental and has much less clinical evidence supporting its use
From this point forward, escalate only one compound at a time
mitochondrial support add Feature Lean mass preservation Advanced Recomp Stack Enhanced via GH + IGF-1 CagriSema Some amylin signal Retatrutide Solo Limited - deficit risk remains Reta + MOTS-c Limited Feature Injection burden Advanced Recomp Stack 1 weekly + daily CJC/Ipa CagriSema 1 weekly combined Retatrutide Solo 1 weekly Reta + MOTS-c 1 weekly + 2-3x weekly MOTS-c Feature Complexity Advanced Recomp Stack High (3 compounds, 3 vials) CagriSema Low (single combo) Retatrutide Solo Low (single) Reta + MOTS-c Moderate Feature Cost Advanced Recomp Stack High CagriSema Moderate Retatrutide Solo Moderate Reta + MOTS-c Moderate-high Feature Evidence level Advanced Recomp Stack Phase 3 (reta) + PK (CJC/Ipa)
No human studies have shown that tirzepatide causes birth defects
